Wu Luo
Datos Biográficos
| ID | 7264392 |
|---|---|
| NOMBRE | Wu Luo |
| NOMBRES | Wu |
| APELLIDO | Luo |
| FIRMA | LUO W |
| AFILIACIONES | Wenzhou Medical University |
| ORCID | 0000-0001-7383-9470 |
| VERIFICADO | No |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2021 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells
Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression
Our findings provide direct evidence that TRAF6 mediates diabetes-induced inflammation leading to renal dysfunction. We also show that KPF is a potential therapeutic agent to reduce inflammatory responses in DN. Also, TRAF6 may represent an interesting target to combat DN
Sin obras prominentes en esta página.
Kaempferol attenuates streptozotocin-induced diabetic nephropathy by downregulating TRAF6 expression
Our findings provide direct evidence that TRAF6 mediates diabetes-induced inflammation leading to renal dysfunction. We also show that KPF is a potential therapeutic agent to reduce inflammatory responses in DN. Also, TRAF6 may represent an interesting target to combat DN
Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells
Apoptosis (1 obras) · Biochemistry (1 obras) · Chemistry (1 obras) · Diabetes mellitus (1 obras) · Diabetic nephropathy (1 obras) · Downregulation and upregulation (1 obras) · Drug-Induced Hepatotoxicity and Protection (1 obras) · Endocrinology (1 obras) · Fibrosis (1 obras) · Gene knockdown (1 obras)